BRK-B vs SHBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
SHBI presents a compelling value opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price of $19.98 that sits significantly below both its Graham Number ($26.59) and estimated Intrinsic Value ($52.51). The company exhibits strong fundamental growth with YoY earnings increasing by 17.9% and a low Forward P/E of 9.22. While technical trends are currently bearish and insider activity is slightly negative, the underlying profitability and valuation gap suggest significant upside potential. The low payout ratio of 26.97% ensures dividend sustainability despite the modest yield.
Compare Another Pair
Related Comparisons
BRK-B vs SHBI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Shore Bancshares, Inc. (SHBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.